- Excellent safety profile with efficacy data (75% bone fusion rate)
- Expected to be used as a reinforcing agent for spinal fusion and implant procedures for disc patients
- DRT-102 shows superior effect and potency to BMP2 in bone fusion model in animal studies (rodent and dog).
- DRT-102 shows clinically superior effect and potency to BMP2 in human trials
